Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.51−0.02 (-1.31%)
Close on Nov 13, 2026Market cap $850.64KP/E –Yield –
Universe Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$2.40B. The highest annual figure on record is $14.04M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$2.40B | – |
| FY2024 | Sep 30, 2024 | -$7.53B | – |
| FY2023 | Sep 30, 2023 | -$3.46B | – |
| FY2022 | Sep 30, 2022 | -$6.49M | -146.2% |
| FY2021 | Sep 30, 2021 | $14.04M | +31.7% |
| FY2020 | Sep 30, 2020 | $10.66M | +4.8% |
| FY2019 | Sep 30, 2019 | $10.17M | – |
See a number that looks wrong?